Novasen 325mg Enteric Coated Tablets (delayed Release) (2017-11-27)

NOVASEN 325mg Enteric Coated Tablets Recall NOVASEN 325mg enteric coated tablets are being recalled across Canada due to product safety concerns. The recall applies to all NOVASEN 325mg delayed-release tablets distributed in Canada. This is classified as a Class I recall, which indicates a serious safety issue.

Reason
Product safety
Classification
Class I
Category
drug recall
Country
Canada
Agency
HC-DRUGS
Recall date
2017-12-07
Status
Closed
Distribution
Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/e54daca0-b7fc-4f61-8ff4-70e16a3c51b3